Novogene Future Growth

Future criteria checks 2/6

Novogene is forecast to grow earnings and revenue by 19.4% and 17.5% per annum respectively. EPS is expected to grow by 18.8% per annum. Return on equity is forecast to be 9.1% in 3 years.

Key information

19.4%

Earnings growth rate

18.8%

EPS growth rate

Life Sciences earnings growth33.4%
Revenue growth rate17.5%
Future return on equity9.1%
Analyst coverage

Low

Last updated29 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:688315 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,128291N/A4164
12/31/20252,623245N/A4825
12/31/20242,262204N/A1585
9/30/20242,092187176336N/A
6/30/20242,06918185256N/A
3/31/20242,03018397251N/A
12/31/20232,002178217334N/A
9/30/20231,990190171280N/A
6/30/20232,006196170319N/A
3/31/20231,980181278465N/A
12/31/20221,92617787304N/A
9/30/20221,955209180398N/A
6/30/20221,914200222386N/A
3/31/20221,888211122247N/A
12/31/20211,866225181293N/A
9/30/20211,812218235340N/A
6/30/20211,707193316413N/A
3/31/20211,633132406518N/A
12/31/20201,49037250342N/A
9/30/20201,437-10-9818N/A
6/30/20201,5509-196-63N/A
3/31/20201,47237-351-214N/A
12/31/20191,535114-8785N/A
9/30/20191,377107-57101N/A
6/30/20191,219100-26117N/A
3/31/20191,1379922134N/A
12/31/20181,0549770151N/A
12/31/201773981N/A55N/A
12/31/201645839N/A95N/A
12/31/201531025N/A143N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688315's forecast earnings growth (19.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 688315's earnings (19.4% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 688315's earnings are forecast to grow, but not significantly.

Revenue vs Market: 688315's revenue (17.5% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 688315's revenue (17.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 688315's Return on Equity is forecast to be low in 3 years time (9.1%).


Discover growth companies